Kalvista Pharmaceuticals Inc
NASDAQ:KALV

Watchlist Manager
Kalvista Pharmaceuticals Inc Logo
Kalvista Pharmaceuticals Inc
NASDAQ:KALV
Watchlist
Price: 11.8 USD -0.76% Market Closed
Market Cap: 586.7m USD

Wall Street
Price Targets

KALV Price Targets Summary
Kalvista Pharmaceuticals Inc

Wall Street analysts forecast KALV stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for KALV is 27.67 USD with a low forecast of 18.18 USD and a high forecast of 40.95 USD.

Lowest
Price Target
18.18 USD
54% Upside
Average
Price Target
27.67 USD
134% Upside
Highest
Price Target
40.95 USD
247% Upside
Kalvista Pharmaceuticals Inc Competitors:
Price Targets
VTGN
VistaGen Therapeutics Inc
414% Upside
ALKS
Alkermes Plc
33% Upside
397030
AprilBio Co Ltd
108% Upside
9926
Akeso Inc
27% Upside
300896
Imeik Technology Development Co Ltd
33% Upside
MDXG
MiMedx Group Inc
90% Upside
EDIT
Editas Medicine Inc
117% Upside
2487
Cutia Therapeutics
14% Upside

Revenue
Forecast

Revenue Estimate
Kalvista Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
13%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Kalvista Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat

Net Income
Forecast

Net Income Estimate
Kalvista Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-60%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is KALV's stock price target?
Price Target
27.67 USD

According to Wall Street analysts, the average 1-year price target for KALV is 27.67 USD with a low forecast of 18.18 USD and a high forecast of 40.95 USD.

Back to Top